يعرض 1 - 20 نتائج من 1,284 نتيجة بحث عن '"Konova, A."', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المصدر: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 24(48):7-13

    مصطلحات موضوعية: Medicin och hälsovetenskap

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المؤلفون: Pazukhina E, Rumyantsev M, Baimukhambetova D, Bondarenko E, Markina N, El-Taravi Y, Petrova P, Ezhova A, Andreeva M, Iakovleva E, Bobkova P, Pikuza M, Trefilova A, Abdeeva E, Galiautdinova A, Filippova Y, Bairashevskaia A, Zolotarev A, Bulanov N, Dunngalvin A, Chernyavskaya A, Kondrikova E, Kolotilina A, Gadetskaya S, Ivanova Y.V, Turina I, Eremeeva A, Fedorova L.A, Comberiati P, Peroni D.G, Nekliudov N, Genuneit J, Reyes L.F, Brackel C.L.H, Mazankova L, Miroshina A, Samitova E, Borzakova S, Carson G, Sigfrid L, Scott J.T, McFarland S, Greenhawt M, Buonsenso D, Semple M.G, Warner J.O, Olliaro P, Osmanov I.M, Korsunskiy A.A, Munblit D, Aktulaeva K, Aldanov I, Alekseeva N, Assanova R, Avagyan A, Babkova I, Baziyants L, Berbenyuk A, Bezbabicheva T, Chayka J, Cherdantseva I, Chervyakova Y, Chitanava T, Chubukov A, Degtiareva N, Demyanov G, Demyanov S, Deunezhewa S, Dubinin A, Dymchishina A, Dzhavadov M, Edilgireeva L, Filippova V, Frumkina Y, Gorina A, Gorlenko C, Gripp M, Grosheva M, Gudratova E, Iakimenko E, Kalinina M, Kharchenko E, Kholstinina A, Kirillov B, Kiseljow H, Kogut N, Kondrashova P, Konova I, Korgunova M, Kotelnikova A, Krupina A, Kuznetsova A, Kuznetsova A.S, Laevskaya A, Laukhina V, Lavginova B, Levina Y, Lidjieva E, Butorina A, Lyaginskaya J, Lyubimova E, Magomedov S, Mamchich D, Minazetdinova R, Mingazov A, Mursalova A, Nikolaeva D, Nikolenko A, Novikov V, Novoselov G, Ovchinnikova U, Palchikova V, Papko K, Pavlova M, Pecherkina A, Permyakova S, Porubayeva E, Presnyakova K, Privalov M, Prutkogliadova A, Pushkareva A, Redya A, Romanenko A, Roshchin F, Salakhova D, Sankova M, Sarukhanyan I, Savina V, Semeniako E, Seregina V, Shapovalova A, Sharbetova K, Shishkina N, Shvedova A, Stener V, Ustyan V, Valieva Y, Varaksina M, Varaksina K, Varlamova E, Vlasova N, Yegiyan M, Ziskina N, Zolochevskaya D, Zuykova E, Sechenov Stop COVID Research Team

    المصدر: Universidad de La Sabana ; Intellectum Repositorio Universidad de La Sabana

    وصف الملف: application/pdf

    Relation: BMC Medicine Vol. 22 N° 1 art. 48; http://hdl.handle.net/10818/61876

  13. 13
    Academic Journal

    المساهمون: Not specified., Отсутствует.

    المصدر: Pediatric pharmacology; Том 20, № 6 (2023); 580–587 ; Педиатрическая фармакология; Том 20, № 6 (2023); 580–587 ; 2500-3089 ; 1727-5776

    وصف الملف: application/pdf

    Relation: https://www.pedpharma.ru/jour/article/view/2382/1552; Ogden CL, Fryar CD, Martin CB, et al. Trends in obesity prevalence by race and Hispanic origin — 1999–2000 to 2017–2018. JAMA. 2020;324(12):1208–1210. doi: https://doi.org/10.1001/JAMA.2020.14590; ВОЗ. Ожирение и избыточный вес // Всемирная организация здравоохранения: официальный сайт. Доступно по: https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight#. Ссылка активна на 12.12.2023.; Петеркова В.А., Безлепкина О.Б., Болотова Н.В., и др. Клинические рекомендации «Ожирение у детей» // Проблемы Эндокринологии. — 2021. — Т. 67. — № 5. — С. 67–83. — doi: https://doi.org/10.14341/probl12802; Грицинская В.Л., Новикова В.П., Хавкин А.И. К вопросу об эпидемиологии ожирения у детей и подростков (систематический обзор и мета-анализ научных публикаций за 15-летний период) // Вопросы практической педиатрии. — 2022. — Т.виде17. — № 2.с— С. 126–135. — doi: https://doi.org/10.20953/1817-7646-2022-2-126-135; Шикалева А.А., Шулаев А.В., Шайдуллина М.Р. К вопросу ожирения среди детей: детское ожирение как медико-социальная проблема // Российский педиатрический журнал. — 2022. — Т. 3. — № 1. — С. 350.; Мильнер Е.Б., Евдокимова Н.В., Новикова В.П. и др. Кардиоваскулярные риски подросткового ожирения // Вопросы практической педиатрии. — 2022. — Т. 17. — № 5. — С. 83–89. — doi: https://doi.org/10.20953/1817-7646-2022-583-89; Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2): e2022060640. doi: https://doi.org/10.1542/PEDS.2022-060640; Drugs@FDA: FDA-Approved Drugs. In: U.S. Food & Drags Administration: Official website. Available online: https://www.accessdata.fda.gov/scripts/cder/daf. Accessed on December 12, 2023.; Ryder JR, Kaizer A, Rudser KD, et al. Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes. 2017;41(1):90–93. doi: https://doi.org/10.1038/IJO.2016.185; Dhillon S. Phentermine/topiramate: pediatric first approval. Paediatr Drugs. 2022;24(6):715–720. doi: https://doi.org/10.1007/S40272-022-00532-Z; FDA. Qsymia: highlights of prescribing information. In: U.S. Food & Drags Administration: Official website. Available online: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022580. Accessed on December 12, 2023.; Введенская И.П. Патофизиологическая коррекция двигательного стереотипа у молодых лиц с нарушением осанки, плоскостопием и ожирением средствами физической терапии // International Journal of Medicine and Psychology. — 2022. — Т. 5. — № 6. — С. 103–108.; Borzutzky C, King E, Fox CK, et al. Trends in prescribing antiobesity pharmacotherapy for paediatric weight management: data from the POWER Work Group. Pediatr Obes. 2021;16(1):e12701. doi: https://doi.org/10.1111/IJPO.12701; Алиева В.А Современные лекарственные препараты в лечении ожирения // Клиническая фармакология и терапия. — 2020. — Т. 29. — № 4. — С. 61–66. — doi: https://doi.org/10.32756/0869-5490-2020-4-61-66; Бибик Е.Ю., Шипилова Н.В., Тильченко Д.А. и др. Эффективность и безопасность средств фармакотерапии алиментарного ожирения на современном этапе (обзор литературы) // Морфологический альманах им. В.Г. Ковешникова. — 2019. — Т. 17. — № 1. — С. 77–85.; Camilleri M, Acosta A. Combination Therapies for Obesity. Metab Syndr Relat Disord. 2018;16(8):390–394. doi: https://doi.org/10.1089/met.2018.0075; Lim S, Rogers LK, Tessler O, et al. Phentermine: a systematic review for plastic and reconstructive surgeons. Ann Plast Surg. 2018;81(4):508. doi: https://doi.org/10.1097/SAP.0000000000001478; Go RE, Hwang KA, Kim SH, et al. Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model. Lab Anim Res. 2014;30(2):73. doi: https://doi.org/10.5625/LAR.2014.30.2.73; Klein S, Romijn JA. Obesity. In: Williams Textbook of Endocrinology. Elsevier; 2016. pp. 1633–1659. doi: https://doi.org/10.1016/B978-0-323-29738-7.00036-8; Murali S. Knowledge gaps in long-term phentermine use: making the case for maintenance. Obesity. 2019;27(8):1219. doi: https://doi.org/10.1002/oby.22516; Lei XG, Ruan JQ, Lai C, et al. Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: a systematic review and meta-analysis. Obesity. 2021;29(6):985–994. doi: https://doi.org/10.1002/OBY.23152; Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France (Regulation). Prescrire Int. 2012;21(130):209.; Sehnert KW. Development of phentermine, an appetite-control drug. Clin Med. 1963;70:400–403.; Khalil NY, AlRabiah HK, Rashoud SS, et al. Topiramate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2019;44:333– 378. doi: https://doi.org/10.1016/BS.PODRM.2018.11.005; Hendricks EJ, Srisurapanont M, Schmidt SL, et al. Addiction potential of phentermine prescribed during long-term treatment of obesity. Int J Obes. 2014;38(2):292–298. doi: https://doi.org/10.1038/IJO.2013.74; Lewis KH, Fischer H, Ard J, et al. Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. Obesity. 2019;27(4):591–602. doi: https://doi.org/10.1002/oby.2243; Ali Ibrahim AI, Mendoza B, Stanford FC, Malhotra S. Real-world experience of the efficacy and safety of phentermine use in adolescents: a case series. Child Obes. 2023;19(8):535–540. doi: https://doi.org/10.1089/CHI.2022.0147; Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: a review. Obesity. 2022;30(4):802–840. doi: https://doi.org/10.1002/oby.23371; Horn DB, Almandoz JP, Look M. What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review. Postgrad Med. 2022;134(4):359–375. doi: https://doi.org/10.1080/00325481.2022.2051366; Fox CK, Marlatt KL, Rudser KD, Kelly AS. Topiramate for weight reduction in adolescents with severe obesity. Clin Pediatr. 2015;54(1):19–24. doi: https://doi.org/10.1177/0009922814542481; Шаймарданова Р.М., Гамирова Р.Г. Долгосрочная эффективность и безопасность противоэпилептических средств у детей и взрослых // Обзоры по клинической фармакологии и лекарственной терапии. — 2021. — Т. 19. — № 2. — С. 221–228. — doi: https://doi.org/10.17816/RCF192221-228; Белоусова Е.Д., Бурд С.Г., Ермоленко Н.А., Мухин К.Ю. Диагностика и возрастная эволюция синдрома Леннокса–Гасто. Ведение пациентов в разных возрастных периодах // Эпилепсия и пароксизмальные состояния. — 2022. — Т. 14. — №3. — С. 276–293. — doi: https://doi.org/10.17749/2077-8333/epi.par.con.2022.124; Shapiro M, Reid A, Olsen B, et al. Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications: a medical record review. Int J Psychiatry Med. 2016;51(1):56–68. doi: https://doi.org/10.1177/0091217415621266; Трошина Е.А., Ершова Е.В. Фармакотерапия ожирения: что нового? // Проблемы Эндокринологии. — 2018. — Т. 64. — № 4. — С. 270–276.; Sweeting AN, Tabet E, Caterson ID, et al. Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate. Diabetes Metab Syndr Obes. 2014;7:35–44. doi: https://doi.org/10.2147/DMSO.S38979; Rafi SK, Goering JP, Olm-Shipman AJ, et al. Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: implications for teratogenicity. PLoS One. 2021;16(2):e0246989. doi: https://doi.org/10.1371JOURNAL.PONE.0246989; Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012;207(5):405. e1–405.e7. doi: https://doi.org/10.1016/j.ajog.2012.07.00; Mines D, Tennis P, Curkendall SM, et al. Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf. 2014;23(10):1017–1025. doi: https://doi.org/10.1002/pds.3612; Mikaeloff Y, De Saint-Martin A, Mancini J, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res. 2003;53(3):225–232. doi: https://doi.org/10.1016/S0920-1211(03)00028-7; Winner P, Pearlman EM, Linder SL, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(10):1304–1312. doi: https://doi.org/10.1111/J.1526-4610.2005.00262.X; Consoli A, Çabal Berthoumieu S, Raffin M, et al. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study. Transl Psychiatry. 2019;9(1):274. doi: https://doi.org/10.1038/S41398-019-0597-0; Fox CK, Kaizer AM, Rudser KD, et al. Meal replacements followed by topiramate for the treatment of adolescent severe obesity: a pilot randomized controlled trial. Obesity. 2016;24(12):2553–2561. doi: https://doi.org/10.1002/OBY.21633; Проскурина И.А., Горская Т.Е., Горячев Д.В. Планирование программы клинических исследований препаратов для лечения ожирения // Ведомости Научного центра экспертизы средств медицинского применения. Регуляторные исследования и экспертиза лекарственных средств. — 2023. — doi: https://doi.org/10.30895/1991-2919-2023-452; Bays H. Phentermine, topiramate and their combination for the treatment of adiposopathy (‘sick fat’) and metabolic disease. Expert Rev Cardiovasc Ther. 2010;8(12):1777–1801. doi: https://doi.org/10.1586/ERC.10.125; Шабутдинова О.Р., Даутов А.Р., Самков А.А. и др. Семаглутид — эффективность в снижении веса и побочные эффекты при применении по данным исследований SUSTAIN, PIONEER, STEP // Проблемы Эндокринологии. — 2023. — Т. 69. — № 3. — С. 68–82. — doi: https://doi.org/10.14341/probl13197; Kiortsis DN. A review of the metabolic effects of controlledrelease phentermine/topiramate. Hormones. 2013;12(4):507–516. doi: https://doi.org/10.14310/HORM.2002.1438; Kelly AS, Bensignor MO, Hsia DS, et al. Phentermine/topiramate for the treatment of adolescent obesity. NEJM Evidence. 2022;1(6):1–11. doi: https://doi.org/10.1056/EVIDOA2200014; Li J, Reaven NL, Funk SE, et al. 4-year cost trajectories in real-world patients matched to the metabolic profiles of trial subjects before/after treatment with phentermine-topiramate. Drugs Real World Outcomes. 2015;2(2):143–151. doi: https://doi.org/10.1007/S40801-015-0021-X; Fox CK, Kelly AS. Pharmacotherapy for severe obesity in children. Clin Pediatr. 2015;54(13):1302. doi: https://doi.org/10.1177/0009922815580407; Nicolucci A, Maffeis C. The adolescent with obesity: what perspectives for treatment? Ital J Pediatr. 2022;48(1):9. doi: https://doi.org/10.1186/S13052-022-01205-W; Raman V, Gupta A, Ashraf AP, et al. Pharmacologic weight management in the era of adolescent obesity. J Clin Endocrinol Metab. 2022;107(10):2716–2728. doi: https://doi.org/10.1210/CLINEM/DGAC418; https://www.pedpharma.ru/jour/article/view/2382

  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal